The emerging treatment of tirzepatide peptide represents a major breakthrough in the handling of the condition. Distinct from existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and GIP – leading to improved sugar management and anticipated weight loss. Experts are studying i